Lexeo Therapeutics Inc (LXEO)

SG&A Expenses

$28.48M

TTM · Period ending: · USD

LXEO logo

LXEO SG&A Expenses

Latest reported$28.48M
LXEO SG&A Expenses ($787.50K → $28.48M)
High-resolution chart · PNG

LXEO sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
45,460,000
31,675,000
15,383,000
12,001,000
7,173,000
787,499
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.